Remove 2018 Remove Pharma Remove Side effects
article thumbnail

Jazz Pharma uses flying pig for huge grey area DTC

World of DTC Marketing

billion in 2018, and is expected to grow at a CAGR of 7.20% to reach $86.01 Given that most obstructive sleep apnea patients are obese men, it’s dangerous that the side effects listed for Sunosi say, “tell your doctor if you have heart problems, high blood pressure, kidney problems, diabetes, or high cholesterol.”

Pharma 181
article thumbnail

Myovant Sciences rejects $2.5bn takeover bid from Sumitomo Pharma

Pharmaceutical Technology

Myovant Sciences has rejected an acquisition offer from Sumitovant Biopharma and its wholly owned subsidiary, Sumitomo Pharma. Most currently available therapeutic options for endometriosis often have a diminished efficacy over time and result in negative side effects such as menopausal-like side effects and bone mineral density (BMD) loss.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Value of Humans in a Tech-Driven World

PM360

Today in pharma, people are asking a similar question: In an era of unprecedented technology, is there still value in the human sales rep? 1 line item in pharma company budgets. I can ask them a specific question about how Im handling a side effect or how often its happening. An Identity Crisis in Pharmaceutical Sales?

Sales 52
article thumbnail

ATRAG formulations for lung disease

European Pharmaceutical Review

Swedish pharmaceutical company Vicore Pharma is developing treatments for diseases where the angiotensin II type 2 receptor (AT2R) has a central role in stopping and reversing disease pathology and where there is a large unmet medical need. The company’s lead candidate, C21, is an angiotensin II type 2 receptor agonist (ATRAG).

Pharma 98
article thumbnail

Valneva’s Lyme disease vaccine faces final clinical test in a sparse landscape

Pharmaceutical Technology

cases per 100,000 people in 2018. “In While there were concerns about Lymerix’s side effects, it was the low demand that led to its withdrawal, says Šíma, adding that VLA15 could be in a similar tough spot when it comes to its position on the market. In the UK, the mean annual incidence of Lyme disease grew from 0.38

Medicine 119
article thumbnail

Can the FDA keep the momentum going for rare disease drug approvals?

Pharmaceutical Technology

In 2022, the FDA approved only 37 new medicines, an underwhelming number compared to 98 in 2018. However, while only around 34% of the approvals in 2018 were for orphan drugs, 54% new approvals in 2022 were for drugs to treat rare diseases. This was not always the case. “Up A major symptom of MCT8 deficiency is an overexpression of T3.

FDA 126
article thumbnail

Elevating Patient Experiences by Breaking Down Internal Silos

PM360

Pharma brands work diligently to win the trust of key stakeholders—namely patients, caregivers, and healthcare providers (HCPs). And with therapy underway, many of these programs help boost adherence¹ by addressing common barriers to compliance, like missed doses, side effects, and unreliable information about the drug and disease.²